Quality-Adjusted Life Years
"Quality-Adjusted Life Years" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)
| Descriptor ID |
D019057
|
| MeSH Number(s) |
E05.318.740.100.500.700 N01.224.935.530.700
|
| Concept/Terms |
Quality-Adjusted Life Years- Quality-Adjusted Life Years
- Life Year, Quality-Adjusted
- Life Years, Quality-Adjusted
- Quality-Adjusted Life Year
- Year, Quality-Adjusted Life
- Years, Quality-Adjusted Life
- Quality Adjusted Life Years
- QALY
Adjusted Life Years- Adjusted Life Years
- Adjusted Life Year
- Life Year, Adjusted
- Life Years, Adjusted
- Year, Adjusted Life
- Years, Adjusted Life
|
Below are MeSH descriptors whose meaning is more general than "Quality-Adjusted Life Years".
Below are MeSH descriptors whose meaning is more specific than "Quality-Adjusted Life Years".
This graph shows the total number of publications written about "Quality-Adjusted Life Years" by people in this website by year, and whether "Quality-Adjusted Life Years" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 3 | 4 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 8 | 9 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 6 | 6 |
| 2017 | 0 | 3 | 3 |
| 2019 | 1 | 3 | 4 |
| 2020 | 0 | 6 | 6 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 5 | 5 |
| 2025 | 0 | 2 | 2 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Quality-Adjusted Life Years" by people in Profiles.
-
Reynolds MR, Pollit V, Schwamm L, Witte KK, Yaghi S, Rose DZ, Cudworth S, Carpenter J, Rosemas SC, Ziegler PD, Neisen K, Franco NC, Bernstein RA. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA. BMJ Open. 2026 Apr 27; 16(4):e103766.
-
Joshi M, Kim K, Pickard AS, Sharp LK, Gerber BS, Touchette DR. Long-term cost-effectiveness of a mobile health intervention delivered by clinical pharmacists and community health workers for type 2 diabetes management in urban African American and Latinx populations. Am J Health Syst Pharm. 2026 Apr 07; 83(8):423-435.
-
G?n?reux P, Reynolds MR, Kelley MA, Thompson C, Baron SJ. Cost-Effectiveness of TAVR Compared With Clinical Surveillance in Patients with Asymptomatic Severe Aortic Stenosis in the United States. Value Health. 2026 Jul; 29(7):1171-1179.
-
Choi SE, Simon L. Projected Outcomes of Removing Fluoride From US Public Water Systems. JAMA Health Forum. 2025 May 02; 6(5):e251166.
-
Socolovsky C, Louisias M, Alsulami S, Petty CR, Trivedi M, Lai PS, Cunningham A, Gaffin J, Thorne P, Coull B, Koutrakis P, Baccarelli A, Gold DR, Adamkiewicz G, Permaul P, Banzon T, Hauptman M, Bartnikas LM, Baxi S, Sheehan WJ, Phipatanakul W, Samnaliev M. Cost-effectiveness of school integrated pest management and air filtration in students with asthma. Allergy Asthma Proc. 2025 05 01; 46(3):257-266.
-
Usta G, Ramsey DJ. Low Vision Services Are Underutilized by Patients with Vision Loss from Corneal Disease. Cornea. 2026 Apr 01; 45(4):421-427.
-
Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP. Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts. JAMA Netw Open. 2024 10 01; 7(10):e2437233.
-
O'Callaghan L, Chertavian E, Johnson SJ, Ferries E, Deligiannidis KM. The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. J Med Econ. 2024 Jan-Dec; 27(1):492-505.
-
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.
-
Wang L, Lauren BN, Hager K, Zhang FF, Wong JB, Kim DD, Mozaffarian D. Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study. J Am Heart Assoc. 2023 08; 12(15):e029215.